Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Doolan

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
The Indian Journal of Medical Research|August 1, 1997
DNA vaccines for malaria: the past, the present, & the futureD L Doolan, R C Hedstrom, R Wang, et al.
Current Topics in Microbiology and Immunology|February 28, 1998
DNA vaccination as an approach to malaria control: current status and strategiesD L Doolan, R C Hedstrom, M J Gardner, et al.
Annals of the New York Academy of Sciences|November 27, 1995
Nucleic acid malaria vaccines. Current status and potentialS L Hoffman, D L Doolan, M Sedegah, et al.
Infection and Immunity|October 26, 1999
CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte proteinY Charoenvit, V F Majam, G Corradin, et al.
Journal of Pharmaceutical Sciences|December 1, 1996
DNA vaccines against malaria: immunogenicity and protection in a rodent modelM J Gardner, D L Doolan, R C Hedstrom, et al.
The Journal of Experimental Medicine|December 1, 1994
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virusV P Argaet, C W Schmidt, S R Burrows, et al.
Vaccine|June 1, 1997
Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human useS L Hoffman, D L Doolan, M Sedegah, et al.
Immunology and Cell Biology|August 1, 1997
Toward clinical trials of DNA vaccines against malariaS L Hoffman, D L Doolan, M Sedegah, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II allelesD L Doolan, S Southwood, R Chesnut, et al.
Immunity|July 1, 1997
Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype allelesD L Doolan, S L Hoffman, S Southwood, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The Indian Journal of Medical Research|August 1, 1997
DNA vaccines for malaria: the past, the present, & the futureD L Doolan, R C Hedstrom, R Wang, et al.
Current Topics in Microbiology and Immunology|February 28, 1998
DNA vaccination as an approach to malaria control: current status and strategiesD L Doolan, R C Hedstrom, M J Gardner, et al.
Annals of the New York Academy of Sciences|November 27, 1995
Nucleic acid malaria vaccines. Current status and potentialS L Hoffman, D L Doolan, M Sedegah, et al.
Infection and Immunity|October 26, 1999
CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte proteinY Charoenvit, V F Majam, G Corradin, et al.
Journal of Pharmaceutical Sciences|December 1, 1996
DNA vaccines against malaria: immunogenicity and protection in a rodent modelM J Gardner, D L Doolan, R C Hedstrom, et al.
The Journal of Experimental Medicine|December 1, 1994
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virusV P Argaet, C W Schmidt, S R Burrows, et al.
Vaccine|June 1, 1997
Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human useS L Hoffman, D L Doolan, M Sedegah, et al.
Immunology and Cell Biology|August 1, 1997
Toward clinical trials of DNA vaccines against malariaS L Hoffman, D L Doolan, M Sedegah, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II allelesD L Doolan, S Southwood, R Chesnut, et al.
Immunity|July 1, 1997
Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype allelesD L Doolan, S L Hoffman, S Southwood, et al.
Pageof 5